Why the study?
Are survivors of childhood acute lymphoblastic leukemia at increased risk of cardiovascular disease?
Population
Survivors of childhood acute lymphoblastic leukemia (ALL)
Design
Review
Authors
Loading...
May warrant CV risk monitoring in childhood ALL survivors; confirms associations but leaves optimal strategies open for prospective trials.
Are survivors of childhood acute lymphoblastic leukemia at increased risk of cardiovascular disease?
Childhood ALL survivors require monitoring for cardiovascular risk factors and late-onset cardiotoxicity from therapies like anthracyclines.
Kevin C. Oeffinger (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: